InvestorsHub Logo
Followers 217
Posts 15877
Boards Moderated 7
Alias Born 06/02/2007

Re: DewDiligence post# 616

Friday, 05/19/2023 6:10:05 PM

Friday, May 19, 2023 6:10:05 PM

Post# of 625
Ocaliva is the classic example of a drug that was approved on the basis of its effects on (alleged) surrogate endpoints while in reality its primary effect was to exacerbate the symptoms of the underlying disease.

Add that to management that is incompetent at best and dishonest at worst and here we are today.

“What gets us into trouble is not what we don't know. It's what we know for sure that just ain't so.”

- Mark Twain

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ICPT News